131 related articles for article (PubMed ID: 32141560)
1. LncRNA AK024094 aggravates the progression of breast cancer through regulating miRNA-181a.
Zheng TZ; Li YT; Li WJ
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1913-1921. PubMed ID: 32141560
[TBL] [Abstract][Full Text] [Related]
2. LncRNA PAPAS aggravates the progression of gastric cancer through regulating miRNA-188-5p.
Shi X; You X; Zeng WC; Deng YJ; Hong HL; Huang OX; Wang MF
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10761-10768. PubMed ID: 31858543
[TBL] [Abstract][Full Text] [Related]
3. TATDN1 promotes the development and progression of breast cancer by targeting microRNA-140-3p.
Yu XY; Tian JR; Yang D; Tan HR
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5293-5300. PubMed ID: 31298381
[TBL] [Abstract][Full Text] [Related]
4. MiRNA-221-5p promotes breast cancer progression by regulating E-cadherin expression.
Niu XY; Zhang ZQ; Ma PL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6983-6990. PubMed ID: 31486498
[TBL] [Abstract][Full Text] [Related]
5. LncRNA HANR aggravates the malignant progression of glioma via targeting miRNA-335.
Wang WJ; Sun K; Li FY; Hui XB; Liu D; Liu J; Wang XD
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):758-765. PubMed ID: 32016979
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MIF-AS1 aggravates the progression of ovarian cancer by sponging miRNA-31-5p.
Fan Y; Wang L; Han XC; Ma HY; Zhang N; Zhe L
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2248-2255. PubMed ID: 32196575
[TBL] [Abstract][Full Text] [Related]
7. LncRNA HANR aggravates the progression of non-small cell lung cancer via mediating miRNA-140-5p.
Li SJ; Wu YX; Liang YH; Gao Y; Wu AB; Zheng HY; Yang ZX
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):704-711. PubMed ID: 32016972
[TBL] [Abstract][Full Text] [Related]
8. LncRNA DLEU1 accelerates the malignant progression of clear cell renal cell carcinoma via regulating miRNA-194-5p.
He GZ; Yu SY; Zhou QP; Chen ML; Zhang YW; Zheng Y; Zhang ZB; Han ZY; Yu J
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10691-10698. PubMed ID: 31858537
[TBL] [Abstract][Full Text] [Related]
9. LncRNA GIHCG regulates microRNA-1281 and promotes malignant progression of breast cancer.
Fan LY; Shi KY; Xu D; Ren LP; Yang P; Zhang L; Wang F; Shao GL
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10842-10850. PubMed ID: 31858553
[TBL] [Abstract][Full Text] [Related]
10. LncRNA AWPPH accelerates the progression of non-small cell lung cancer by sponging miRNA-204 to upregulate CDK6.
Wu D; Qin BY; Qi XG; Hong LL; Zhong HB; Huang JY
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4281-4287. PubMed ID: 32373964
[TBL] [Abstract][Full Text] [Related]
11. LncSNHG14 promotes the development and progression of bladder cancer by targeting miRNA-150-5p.
Li J; Wang AS; Wang S; Wang CY; Xue S; Guan H; Li WY; Ma TT; Shan YX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1022-1029. PubMed ID: 30779068
[TBL] [Abstract][Full Text] [Related]
12. LncRNA SNHG12 accelerates the progression of ovarian cancer via absorbing miRNA-129 to upregulate SOX4.
Sun D; Fan XH
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2345-2352. PubMed ID: 30964158
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-1236-3p inhibits proliferation and invasion of breast cancer cells by targeting ZEB1.
Liang TC; Fu WG; Zhong YS
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9988-9995. PubMed ID: 31799668
[TBL] [Abstract][Full Text] [Related]
14. MiRNA-802 inhibits the metastasis of colorectal cancer by targeting FOXE1.
Zhang Y; Ma LN; Xie Y
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1778-1785. PubMed ID: 32141546
[TBL] [Abstract][Full Text] [Related]
15. LINC01308 accelerates the malignant progression of ovarian cancer by binding to miRNA-506.
Zhang YY; Li P; Zhu MZ; Guo Y; Yang J
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3253-3260. PubMed ID: 31081077
[TBL] [Abstract][Full Text] [Related]
16. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
Luo X; Song Y; Tang L; Sun DH; Ji DG
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
[TBL] [Abstract][Full Text] [Related]
17. LncRNA ITGB1 promotes the development of bladder cancer through regulating microRNA-10a expression.
Dai L; Chai CM; Shen TY; Tian Y; Shang ZQ; Niu YJ
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6858-6867. PubMed ID: 31486485
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA LINC00665 promotes metastasis of breast cancer cells by triggering EMT.
Zhou JL; Zou L; Zhu T
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3097-3104. PubMed ID: 32271427
[TBL] [Abstract][Full Text] [Related]
19. LncRNA RUSC1-AS1 promotes the proliferation of breast cancer cells by epigenetic silence of KLF2 and CDKN1A.
Hu CC; Liang YW; Hu JL; Liu LF; Liang JW; Wang R
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6602-6611. PubMed ID: 31378902
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-9501 inhibits breast cancer proliferation and metastasis through regulating Wnt/β-catenin pathway.
Que LM; Yang XR; Zhang YC; Zhong H
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4337-4347. PubMed ID: 32373971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]